Vas Narasimhan

Vas Narasimhan

CEO Switzerland

Vas Narasimhan is the Chief Executive Officer of Novartis, a leading global healthcare company. Under his leadership, he has focused on advancing innovative therapies while addressing challenges in healthcare costs and access. Narasimhan advocates for sustainable practices in the pharmaceutical industry, emphasizing the need for ethical pricing of medications to ensure that life-saving treatments are accessible to all patients.

Global Media Ratings
Dominance
0.00%
Persistence
2 wks
Reach
210,324
Power
2,976$
Sentiment
8.50
Countries Mentioned
Country Mentions Sentiment Dominance + Persistence x Population = Reach x GDP (millions) = Power
Switzerland 3 6.00 0.21% +20% 8,654,622 21,941 $700,000 1,775$
United Kingdom 1 9.00 0.04% +0% 67,886,011 23,920 $2,700,000 951$
Ghana 1 8.00 0.13% +0% 31,072,945 41,709 $67,000 90$
Tanzania 1 9.00 0.15% +0% 59,734,213 89,826 $63,000 95$
Kenya 1 8.00 0.06% +0% 53,771,296 32,928 $106,000 65$
Totals 7 221,119,087 210,324 $3,636,000 2,976$
Interactive World Map

Each country's color is based on "Mentions" from the table above.

Recent Mentions

Switzerland Switzerland: Novartis CEO Vas Narasimhan received one of Trump's letters and criticized the Europeans for not paying enough for innovative drugs. 5

Neue Zürcher Zeitung: Donald Trump fordert tiefere Medikamentenpreise innert 60 Tagen

Switzerland Switzerland: Vas Narasimhan, the CEO of Novartis, reaffirmed his claim that drug prices in Europe need to rise significantly. 6

Neue Zürcher Zeitung: Aus Sorge um Zölle lässt Roche den Ausblick lieber unverändert

Switzerland Switzerland: Vas Narasimhan is the CEO of the pharmaceutical company Novartis and advocates for higher medication prices in Europe. 7

Neue Zürcher Zeitung: Novartis-Chef fordert höhere Medikamentenpreise in Europa

Kenya Kenya: Novartis CEO Vas Narasimhan remarked, 'For more than three decades, we have stayed the course in the fight against malaria.' 8

The Standard: Kenya takes part in trials of first malaria treatment for newborns

Tanzania Tanzania: Vas Narasimhan is the CEO of Novartis and has been working tirelessly to combat malaria. 9

Mwananchi: Dawa ya malaria kwa watoto wachanga yaidhinishwa

Ghana Ghana: Vas Narasimhan, the chief executive of Novartis, says this is an important moment in the fight against malaria. 8

Daily Graphic – state-owned Ghanaian newspaper, est. 1950: First malaria treatment for babies approved for use

United Kingdom United Kingdom: Vas Narasimhan, the chief executive of Novartis, emphasizes the importance of the new malaria treatment for newborns and young babies. 9

BBC: First malaria vaccine for babies approved for use

Switzerland Switzerland: Vas Narasimhan is the CEO of Novartis and has significantly transformed the company during his tenure. 7

Neue Zürcher Zeitung: Vas Narasimhan und Srishti Gupta